Zika Virus Testing Market Size & Analysis, Sector / Industry Report & Analysis, 2018-2027 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Zika Virus Testing Market


The global zika virus Testing market size was valued at USD 131.9 million in 2016. It is projected to exhibit a CAGR of 7.6% over the forecast period. Involvement of international organizations, such as UNICEF, and national governments in low-income developing regions is one of the key trends stimulating market growth. In addition, zika virus (ZIKV) outbreak in 2016 has helped the market gain tremendous traction.
 
In this market, Brazil recorded the highest number of microcephaly cases, close to 1,950, from 2015 to 2016. Zika virus was declared a threat to public health in October 2016 after Brazilian authorities discovered a correlation between ZIKV infection and neurological birth defects. This recently drawn connection between microcephaly in newborns with ZIKV infection has raised surveillance efforts and the demand for diagnostics after the end of Zika epidemic in 2016.As of April 2017, CDC reported that 5,264 people were infected with Zika in the U.S., where more than 1,700 pregnant women were found Zika-positive and 58 babies were born with birth defects.
Zika epidemic in 2016 was largely a result of travel-related transmission in certain countries. In the U.S., 4,830 cases of travel-related Zika virus infections, which accounted for 94.0% of the total case counts in 2016, were reported. Hence, blood screening for Zika infection has been incorporated in addition to testing of symptomatic cases to prevent disease transmission, which is driving the demand for ZIKV diagnostics. The U.S. and Singapore markets, primarily, follow diagnostic testing of blood donations for Zika virus infections.
Organizations such as WHO, PAHO, and UNICEF initiated response strategies for Zika outbreak as the socioeconomic impact, felt globally, was severe. These strategies range from arranging diagnostics to disease treatment reserves. Apart from funding therapeutic and prophylactic research for Zika virus disease, the organizations are leaning toward stockpiling diagnostics for emergencies in the future, which is supporting the growth of the market.
Development of POC diagnostics that yield rapid results is likely to shape the future of the market. UNICEF along with PAHO is offering advanced purchasing commitments (APC) tenders to encourage production of rapid diagnostics for zika virus detection. These APCs serve ZIKV endemic regions that are at risk of witnessing future outbreaks and require rapid diagnostic tests. Chembio Diagnostics Systems, Inc. and SD Biosensors, Inc. sealed UNICEF contracts for supply of their Zika detection tests valid through 2019.

Market Segmentation, Outlook & Viewpoint: Global Zika Virus Testing Market


Test Type Market Segmentation & Outlook (Revenue, USD Million, 2016 - 2025)

Nucleic Acid Amplification Testing (NAAT)

Serological Testing


Key Players, Recent Developments & Regional Insights: Global Zika Virus Testing Market


Both diagnostic test types, NAAT and serological testing, held nearly equal market shares in 2016 as during the epidemic, both tests were performed on the majority of subjects, to confirm ZIKV infection. However, the NAAT segment edged over by a small margin as it is more widely available and can be used for large scale surveillance with cost-effectiveness.
 
With the end of epidemic in early 2017, serological diagnostics started gaining preference to NAAT as they can detect acute as well as late-stage ZIKV infection. In addition, emerging rapid detection serological diagnostics offer shorter turnaround time as well as differential diagnosis of Zika against other flaviviruses.

Regional Insights
From a geographical standpoint, the zika virus diagnostics market is classified into the U.S. States and territories, Europe, Asia Pacific, Latin America, and Africa.
In 2016, the U.S. states and territories dominated the market. Since the outbreak, the U.S. has developed a national response framework to prevent virus spread across the country by collaborating with organizations, such as the CDC, WHO, and PAHO. The country-wide mandate that was passed in 2016, requiring all donated blood to undergo individual donor-NAAT screening for Zika virus is the underlying factor contributing to the growth of the regional market.
Latin America was the second largest market in 2016 and it accounted for more than 50% of the global ZIKV infections. In addition, the presence of vector, Aedes aegypti mosquitoes, increases the chances of viral growth in this region. More than 4,000 suspected cases of microcephaly in newborns were reported in Brazil in the span of four months, from October 2015 to January 2016. Availability of funding worth USD 136.6 million from Brazil’s National Development Bank (BNDES), announced in March 2016, to fight vector-borne illnesses including ZIKV is also working in favor of the regional market.
Zika Virus Testing Market Share Insights
Competition among the market players is high. During Zika epidemic in 2016, Roche; Quest Diagnostics, Inc.; and Hologic, Inc. were the leading market players with FDA-EUA approved products.
End of the epidemic phase led to changes in the competitive landscape of the market.
In early 2017, companies, including Chembio Diagnostic Systems, Inc.; SD Biosensors, Inc.; and Biocan Diagnostics introduced improved diagnostics.With the recent contract received from UNICEF worth USD 10.5 million, Chembio Diagnostics, Inc. is expected to be the leading market player over the forecast period.

Key Insights Covered: Global Zika Virus Testing Market
1.  North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Zika Virus Testing industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Zika Virus Testing industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Zika Virus Testing industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Zika Virus Testing industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Zika Virus Testing industry.

Research Methodology: Global Zika Virus Testing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other